Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: erlotinib hydrochloride
Sponsor: National Cancer Institute (NCI)